SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-282668
Filing Date
2022-11-10
Accepted
2022-11-10 16:27:04
Documents
14
Period of Report
2022-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d377760d8k.htm   iXBRL 8-K 24160
2 EX-99.1 d377760dex991.htm EX-99.1 72533
6 GRAPHIC g377760dsp100.jpg GRAPHIC 6330
  Complete submission text file 0001193125-22-282668.txt   240356

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vinc-20221110.xsd EX-101.SCH 2846
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vinc-20221110_lab.xml EX-101.LAB 18739
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vinc-20221110_pre.xml EX-101.PRE 11701
8 EXTRACTED XBRL INSTANCE DOCUMENT d377760d8k_htm.xml XML 3468
Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Filer) CIK: 0001796129 (see all company filings)

IRS No.: 833197402 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39244 | Film No.: 221377696
SIC: 2834 Pharmaceutical Preparations